PROGRESSARE MEDINVEST B V has a total of 15 patent applications. Its first patent ever was published in 2010. It filed its patents most often in Australia, China and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, medical technology and organic fine chemistry are SCARCELL THERAPEUTICS, ACERUS BIOPHARMA INC and BIOACTIVES INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 2 | |
#2 | China | 2 | |
#3 | EPO (European Patent Office) | 2 | |
#4 | Russian Federation | 2 | |
#5 | United States | 2 | |
#6 | WIPO (World Intellectual Property Organization) | 2 | |
#7 | Brazil | 1 | |
#8 | Canada | 1 | |
#9 | Hong Kong | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Medical technology | |
#3 | Organic fine chemistry | |
#4 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Syringes | |
#4 | Specific use of cosmetics | |
#5 | Climate change adaptation technologies |
# | Name | Total Patents |
---|---|---|
#1 | Hendriks Maikel | 13 |
#2 | Bouter Pieternella | 12 |
#3 | Kolodziej Katarzyna | 11 |
#4 | Bauter Piternella | 2 |
#5 | Khendriks Majkel | 2 |
#6 | Kolodzej Katarzhina | 2 |
#7 | Van Den Ende Maarten | 2 |
#8 | Bouter Pieternella Anna Maria | 1 |
Publication | Filing date | Title |
---|---|---|
EP2662086A1 | Composition for the treatment or prevention of urinary tract infections and dosage form | |
EP2407151A1 | Composition for the treatment of skin and/or nail lesions |